Rafael Tordjman, Director, 10% Owner at Flexion Therapeutics Inc (FLXN), bought 1,845,151 shares at $13.00 ($3.0M) on 2014-02-18, disclosed to the SEC on 2014-02-20.
Open-market purchase of $3.0M FLXN by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,614,382 | $0 | 0.0% |
| 2 | $13.00 | 230,769 | $3.0M | 100.0% |
| Total | $1.63 avg | 1,845,151 | $3.0M | 100% |